---
title: "IF=42.5！恭喜北大张泽民团队拿下顶刊《Cell》! 全球首个泛癌症B细胞"地图"绘成 !"
date: 2026-02-05T12:04:39Z
draft: ["false"]
tags: [
  "fetched",
  "生信图Bioinfo"
]
categories: ["Acdemic"]
---
IF=42.5！恭喜北大张泽民团队拿下顶刊《Cell》! 全球首个泛癌症B细胞"地图"绘成 ! by 生信图Bioinfo
------
<div><h1 data-tool="mdnice编辑器" data-pm-slice="0 0 []"><span><span leaf="">文献学习</span></span></h1><section nodeleaf=""><img data-aistatus="1" data-backh="448" data-backw="530" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_png/Dk9Mia6Xic16viaT63Hd0HAqjmFDcD35ib73a6PZb7qibNKhSofA6mEZpMgFrP2sRb6JZQKMp8KMPyZBNFOf6DudG9Q/0?wx_fmt=png&amp;from=appmsg" data-cropx1="54.35294117647059" data-cropx2="1083.1764705882354" data-cropy1="23.294117647058826" data-cropy2="892.9411764705883" data-imgfileid="100001646" data-ratio="0.8454810495626822" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/Dk9Mia6Xic16viaT63Hd0HAqjmFDcD35ib73HEGSgLDzjwGLY0zibmAaicY5eQPzXtOwuYibuiaxia5G8b1XSanrsJuBYsw/640?wx_fmt=jpeg" data-type="png" data-w="1029" type="block" src="https://mmbiz.qpic.cn/mmbiz_jpg/Dk9Mia6Xic16viaT63Hd0HAqjmFDcD35ib73HEGSgLDzjwGLY0zibmAaicY5eQPzXtOwuYibuiaxia5G8b1XSanrsJuBYsw/640?wx_fmt=jpeg"></section><p data-pm-slice="0 0 []"><span><font face="Segoe UI"><span leaf=""><span textstyle="">本次分享的文献是由</span></span><span leaf=""><span textstyle="">北京大学</span><span textstyle="">张泽民团队</span></span><span leaf=""><span textstyle="">在《</span></span></font><span leaf=""><span textstyle="">Cell</span></span><font face="Segoe UI"><span leaf=""><span textstyle="">》（中科院1区Top，IF=42.5）上发表了题为</span><span textstyle="">“</span></span><span leaf=""><span textstyle="">Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes</span></span><span leaf=""><span textstyle="">”</span><span textstyle="">的研究论文，</span></span><span data-pm-slice="0 0 []"><span leaf="">该研究通过整合来自19种癌症类型、649名患者的单细胞RNA测序数据，构建了一个全面的</span></span><strong><span leaf="">肿瘤浸润B细胞（TIBs）图谱</span></strong><span><span leaf="">，系统揭示了TIBs在不同癌症中的异质性，并鉴定出一种</span></span><strong><span leaf="">肿瘤相关非典型B细胞（TAABs）</span></strong><span><span leaf="">亚型，该亚型具有克隆扩增、高活化状态、与CD4⁺ T细胞相互作用密切，且与患者良好预后及免疫治疗响应相关。</span></span></font></span></p><h2 data-tool="mdnice编辑器"><span><span leaf="">研究背景</span></span></h2><section><span leaf=""><span textstyle="">癌症免疫治疗的发展推动了对肿瘤微环境的深入探索，</span></span><strong data-pm-slice="0 0 []"><span leaf=""><span textstyle="">肿瘤浸润 T 细胞和髓系细胞的异质性图谱已助力新治疗策略开发</span></span></strong><span leaf=""><span textstyle="">，但</span></span><strong><span leaf=""><span textstyle="">肿瘤浸润 B 细胞（TIBs）的组成与功能异质性仍缺乏系统性解析</span></span></strong><span leaf=""><span textstyle="">。现有研究表明 B 细胞可通过产生抗体、形成三级淋巴结构参与抗肿瘤免疫，且与免疫治疗响应及患者预后相关，然而</span></span><strong><span leaf=""><span textstyle="">其在泛癌层面的共有特征、特异亚型及作用机制尚未明确</span></span></strong><span leaf=""><span textstyle="">，亟需构建大规模泛癌 B 细胞图谱以填补该研究空白。</span></span></section><section><span><span leaf="">研究数据</span></span></section><p><span leaf=""><span textstyle="">核心数据集：</span><span textstyle="">511,847个B细胞的scRNA-seq数据，来自948个样本、649名患者、19种癌症。</span></span></p><p><span leaf=""><span textstyle="">辅助数据集：</span><span textstyle="">59,592个细胞的BCR序列；乳腺癌scATAC-seq数据；80例组织的IHC/mIHC数据；免疫治疗患者的bulkRNA-seq数据；体外诱导实验的流式数据。</span></span></p><p><span leaf=""><span textstyle="">公共数据：</span><span textstyle="">TCGA预后数据、多个免疫治疗队列数据（如黑色素瘤、非小细胞肺癌的抗PD-1治疗队列）。</span></span></p><p><span leaf=""><span textstyle="">在线资源：</span><span textstyle="">开发交互式网站（http://pan-b.cancer-pku.cn/）共享数据和分析结果。</span></span></p><section><span><span leaf="">研究方法</span></span></section><p><span leaf=""><span textstyle="">多组学数据整合与分析</span></span></p><ul><li><p><span leaf=""><span textstyle="">整合649名患者的scRNA-seq数据，涵盖19种癌症，通过Harmony去除批次效应，鉴定B细胞亚群。</span></span></p></li><li><p><span leaf=""><span textstyle="">利用TRUST4重建59,592个B细胞的BCR序列，分析克隆扩增和体细胞高频突变（SHM）。</span></span></p></li><li><p><span leaf=""><span textstyle="">结合单细胞ATAC-seq数据，解析TAABs的表观遗传特征。</span></span></p></li></ul><p><span leaf=""><span textstyle="">空间表型分析:</span><span textstyle="">对80例石蜡包埋组织进行多重免疫组化（mIHC）和CODEX染色，分析B细胞亚群的空间分布及与其他免疫细胞的互作。</span></span></p><p><span leaf=""><span textstyle="">功能验证实验</span></span></p><ul><li><p><span leaf=""><span textstyle="">体外诱导实验验证FCRL4+B细胞的产生条件。</span></span></p></li><li><p><span leaf=""><span textstyle="">流式细胞术分析肿瘤组织中TAABs的标志物表达。</span></span></p></li></ul><p><span leaf=""><span textstyle="">生物信息学分析</span></span></p><ul><li><p><span leaf=""><span textstyle="">用CellChat分析细胞间通讯；RNAvelocity和CellRank预测细胞分化轨迹。</span></span></p></li><li><p><span leaf=""><span textstyle="">结合TCGA数据和免疫治疗队列数据，分析B细胞亚群的预后和治疗预测价值。</span></span></p></li></ul><section><span><span leaf="">研究结果</span></span></section><p><span leaf=""><span textstyle="">1.构建泛癌B细胞单细胞图谱：</span><span textstyle="">鉴定出5个主要谱系和20个精细亚群，包括TAABs（FCRL4+）和应激反应记忆B细胞（c06_Bm）两个泛癌共享的肿瘤富集亚群。</span></span></p><p><span leaf=""><span textstyle="">2.TIBs的泛癌异质性特征：</span><span textstyle="">不同癌症中TIBs丰度差异显著，鼻咽癌（NPC）中最高，葡萄膜黑色素瘤（UM）中最低；黏膜来源癌症的肿瘤与癌旁B细胞丰度呈正相关。</span></span></p><p><span leaf=""><span textstyle="">3.肿瘤内生发中心反应的存在：</span><span textstyle="">鉴定出明区样（c12）和暗区样（c13）生发中心B细胞，二者可循环转换并积累SHM，最终分化为记忆B细胞和浆细胞。</span></span></p><p><span leaf=""><span textstyle="">4.抗体分泌细胞的同型转换：</span><span textstyle="">肿瘤中抗体分泌细胞（ASCs）存在从IgA到IgG的同型转换，IgG+ASCs具有更高的克隆扩增能力，与抗肿瘤免疫相关。</span></span></p><p><span leaf=""><span textstyle="">5.TAABs的功能特征与临床价值：</span></span></p><ul><li><p><span leaf=""><span textstyle="">TAABs具有高克隆扩增、高增殖能力，高表达MHC-II和共刺激分子（CD80/CD86），可与CD4T细胞紧密互作并激活后者。</span></span></p></li><li><p><span leaf=""><span textstyle="">TAABs与患者良好预后相关，可独立预测免疫治疗响应；应激反应记忆B细胞则与不良预后相关。</span></span></p></li></ul><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001670" data-ratio="1.2307692307692308" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkTiasd5ZLjWwllabyKK02GfyfYVBL4bWsIBzMwWAHB3TQQHoWmNhlQF9Zvkib1oeHt7shMK0Aop4JtdPjTibRumzZh8n0njfpW08/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1508" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkTiasd5ZLjWwllabyKK02GfyfYVBL4bWsIBzMwWAHB3TQQHoWmNhlQF9Zvkib1oeHt7shMK0Aop4JtdPjTibRumzZh8n0njfpW08/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 1：</span><span textstyle=""> </span></span><span leaf=""><span textstyle="">泛癌 TIBs 单细胞图谱构建与亚群鉴定</span></span></span></section><p><span leaf=""><span textstyle="">研究整合了19种癌症、649例患者的scRNA-seq数据，结合BCR重建和mIHC，用Harmony去批次效应，无监督聚类分群并进行基因集富集分析。鉴定出5大B细胞谱系（幼稚、记忆、生发中心、浆细胞、循环B细胞）和20个精细亚群，包括肿瘤相关非典型B细胞（TAABs）和应激反应记忆B细胞；BCR分析显示幼稚B细胞低somatic hypermutation（SHM），记忆/生发中心/浆细胞中高SHM；生发中心和记忆B细胞主要位于三级淋巴结构（TLS）。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001671" data-ratio="1.1212962962962962" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3Ilfk0qGTALPQFjmX48dLGpZrGxg2iaYSzxySstXW2oYmzTKDMWNyOleUL2IMA4pDic5FvzF6PBWVR0RcWKmreVTvzqBmQYgbaME8/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3Ilfk0qGTALPQFjmX48dLGpZrGxg2iaYSzxySstXW2oYmzTKDMWNyOleUL2IMA4pDic5FvzF6PBWVR0RcWKmreVTvzqBmQYgbaME8/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 2：  </span></span><span leaf=""><span textstyle="">TIBs 在泛癌中的丰度与组成异质性</span></span></span></section><p><span leaf=""><span textstyle="">比较了19种癌症肿瘤、癌旁及外周血中TIBs占CD45+细胞比例，通过聚类分析亚群组成相似度，结合CellChat分析TME对B细胞浸润的影响。得出TIBs丰度癌种差异显著（鼻咽癌29.5%vs葡萄膜黑色素瘤近0%）；黏膜来源癌症（结直肠癌、胃癌）肿瘤与癌旁B细胞丰度正相关；结直肠癌和胃癌TIBs亚群组成高度相似，受器官背景调控。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001672" data-ratio="1.3" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3InO0x5KCiaGhpwVCfycwia2TIe38iabrAlbUG6iard0a9JKdI8NquX8F5zIlJIU9qAib3VichMmB9fakYVWXic9NeP0LPfAAaU9CiaI3mA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3InO0x5KCiaGhpwVCfycwia2TIe38iabrAlbUG6iard0a9JKdI8NquX8F5zIlJIU9qAib3VichMmB9fakYVWXic9NeP0LPfAAaU9CiaI3mA/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 3：</span></span><span leaf=""><span textstyle="">肿瘤内生发中心反应的再现</span></span></span></section><p data-pm-slice="0 0 []"><span><font face="宋体"><span leaf=""><span textstyle="">本研究分析生发中心</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">B</span></span></font><font face="宋体"><span leaf=""><span textstyle="">细胞（</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">Bgc</span></span></font><font face="宋体"><span leaf=""><span textstyle="">）亚群的转录特征、</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">BCR</span></span></font><font face="宋体"><span leaf=""><span textstyle="">克隆共享关系，构建谱系树，关联</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">CD4T</span></span></font><font face="宋体"><span leaf=""><span textstyle="">细胞亚群。鉴定出</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">LZ</span></span></font><font face="宋体"><span leaf=""><span textstyle="">样（</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">c12</span></span></font><font face="宋体"><span leaf=""><span textstyle="">，抗原呈递相关）和</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">DZ</span></span></font><font face="宋体"><span leaf=""><span textstyle="">样（</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">c13</span></span></font><font face="宋体"><span leaf=""><span textstyle="">，增殖相关）两个</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">Bgc</span></span></font><font face="宋体"><span leaf=""><span textstyle="">亚群，二者循环转换并积累</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">SHM</span></span></font><font face="宋体"><span leaf=""><span textstyle="">；与</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">CD4</span></span></font><font face="宋体"><span leaf=""><span textstyle="">滤泡辅助</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">T</span></span></font><font face="宋体"><span leaf=""><span textstyle="">细胞（</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">Tfh</span></span></font><font face="宋体"><span leaf=""><span textstyle="">）强正相关；可通过克隆演化分化为记忆</span></span></font><font face="Calibri"><span leaf=""><span textstyle="">B</span></span></font><font face="宋体"><span leaf=""><span textstyle="">细胞和浆细胞。</span></span></font></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001673" data-ratio="1.2805555555555554" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3Imldd88K1XWoJdicpqM5GnXicfV6DdbwZLOzjcBgicF1xQxDzicicuS9Y5RJPgtnibTxY25iao1O2q5E2icYCaJZxujvLyMSL6lDCCud1Y/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3Imldd88K1XWoJdicpqM5GnXicfV6DdbwZLOzjcBgicF1xQxDzicicuS9Y5RJPgtnibTxY25iao1O2q5E2icYCaJZxujvLyMSL6lDCCud1Y/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 4：肿瘤相关免疫反应的关键 B 细胞亚群筛选</span></span></span></section><p><span leaf=""><span textstyle="">研究比较了血液、癌旁、肿瘤中B细胞亚群分布，分析不同亚群克隆大小，检测浆细胞（ASC）免疫球蛋白同型组成。得出关键结果：TAABs（c08）和IgG浆细胞（c16）特异性肿瘤富集；肿瘤内IgG浆细胞克隆扩增水平显著高于癌旁；ASC存在从IgA到IgG的同型转换，IgG1是肿瘤内最主要亚型。</span></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3Ing53T9VdOzNbZsqDfBpghTIEMicp5opHXhFmsE8TshkJ3u89gdhVfTd3RicAIWHwKLiaDSiaI61icJjWKEoUddxatcib6s8krPZP0iaM/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.9166666666666666" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="100001674" data-aistatus="1" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3Ing53T9VdOzNbZsqDfBpghTIEMicp5opHXhFmsE8TshkJ3u89gdhVfTd3RicAIWHwKLiaDSiaI61icJjWKEoUddxatcib6s8krPZP0iaM/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 5：</span></span><span leaf=""><span textstyle="">B 细胞亚群的预后关联分析</span></span></span></section><p><span leaf=""><span textstyle="">该研究结合TCGA泛癌生存数据，用Cox比例风险模型分析亚群签名与总生存期的关联，构建SMART-seq2atlas验证IL10+B细胞特征。关键结果：TAABs签名与泛癌良好预后相关，部分癌种（鼻咽癌、肝癌）关联显著；c06应激反应记忆B细胞与不良预后相关；IL10+B细胞无明确谱系归属，为不同分化阶段的功能状态。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-backh="751" data-backw="578" data-imgfileid="100001675" data-ratio="1.299860529986053" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3In9vUeFd8pDRGN6PnvOSJArzFrFTQzcKO9A2of9oespygNx929M9xpla21P98iakO4iadksCfjIwujdtciaHlD14XLDiaaZpoYqcws/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1434" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3In9vUeFd8pDRGN6PnvOSJArzFrFTQzcKO9A2of9oespygNx929M9xpla21P98iakO4iadksCfjIwujdtciaHlD14XLDiaaZpoYqcws/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 6：</span></span><span leaf=""><span textstyle="">TAABs 的分子特征与发育轨迹</span></span></span></section><p><span leaf=""><span textstyle="">实验通过scATAC-seq分析染色质可及性，RNAvelocity和CellRank推断发育轨迹，流式验证表型，体外诱导实验探索分化条件。得出结论，TAABs表观遗传独特，FCRL4等标志物基因区域染色质开放；起源于c04经典记忆B细胞和c07IFN反应记忆B细胞，为终末分化状态；癌胚抗原（CEA）+CpG+抗CD40组合可有效体外诱导FCRL4+B细胞。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-backh="630" data-backw="578" data-imgfileid="100001677" data-ratio="1.08984375" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkdyO5ePvhUibrB1YtJNq3wN30WecqBpHV0SGvsdHoZrF4G4F51n4ysRY5QyHNV6gbOfdneXzdHO1PUW8tfShZ9yyAobaWGxeBQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1536" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkdyO5ePvhUibrB1YtJNq3wN30WecqBpHV0SGvsdHoZrF4G4F51n4ysRY5QyHNV6gbOfdneXzdHO1PUW8tfShZ9yyAobaWGxeBQ/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 7：</span></span><span leaf=""><span textstyle="">TAABs 与 CD4 T 细胞互作及免疫治疗预测价值</span></span></span></section><p><span leaf=""><span textstyle="">实验以mIHC分析空间邻近关系，CellChat预测细胞通讯，结合7个免疫治疗队列验证亚群签名的预测价值。关键结果：TAABs与CD4T细胞空间邻近（中位距离～10μm），通过MHC-II和CD86-CD28通路激活CD4T细胞；TAABs与CXCL13+CD4T细胞共现；TAABs签名在黑色素瘤和非小细胞肺癌中可预测免疫治疗响应。</span></span></p><section><span><span leaf="">讨论</span></span></section><ul><li><p><strong><span leaf="">临床价值</span></strong><span leaf="">：</span></p></li><ul><li><p><span leaf="">TAABs可作为潜在的预后标志物与免疫治疗响应预测因子。</span></p></li><li><p><span leaf="">为开发B细胞靶向免疫疗法（如增强TAABs功能）提供了理论基础。</span></p></li></ul><li><p><strong><span leaf="">技术亮点</span></strong><span leaf="">：</span></p></li><ul><li><p><span leaf="">大规模数据整合与多层次分析（转录组、BCR、表观、空间）。</span></p></li><li><p><span leaf="">结合多种计算与实验方法，系统解析B细胞发育与功能。</span></p></li><li><p><span leaf="">提供开放访问的数据平台（http://pan-b.cancer-pku.cn/），促进后续研究。</span></p></li></ul></ul><ul></ul><section data-pm-slice="9 11 []"><section data-pm-slice="3 3 []"><p><span leaf=""><span textstyle="">参考文献：</span></span><span data-pm-slice="0 0 []"><span leaf="">Yang Y, Chen X, Pan J, Ning H, Zhang Y, Bo Y, Ren X, Li J, Qin S, Wang D, Chen MM, Zhang Z. Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes. Cell. 2024 Aug 22;187(17):4790-4811.e22. doi: 10.1016/j.cell.2024.06.038. Epub 2024 Jul 23. </span></span></p></section></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/CmhPqzKmU27N6TxQInqMdA",target="_blank" rel="noopener noreferrer">原文链接</a>
